Showing results (1121-1130 of 1,287) with videos related to

Sort By:
Pageof 129
Infection Control and Hospital Epidemiology|November 27, 2019
Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015-2017Lindsey M Weiner-Lastinger, Sheila Abner, Jonathan R Edwards, et al.
Urology|January 25, 2019
The Prevalence of Bladder Cancer During Cystoscopy for Asymptomatic Microscopic HematuriaAshley N Gonzalez, Michael J Lipsky, Gen Li, et al.
Oncogene|July 26, 2011
Dual inhibition of SRC and Aurora kinases induces postmitotic attachment defects and cell deathV Ratushny, H B Pathak, N Beeharry, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 2, 2005
Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonistE S Burstein, J Ma, S Wong, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2007
Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinomaAndre A Konski, Jonathan D Cheng, Melvyn Goldberg, et al.
Cancer Research|September 3, 2004
A single treatment of yttrium-90-labeled CHX-A"-C6.5 diabody inhibits the growth of established human tumor xenografts in immunodeficient miceGregory P Adams, Calvin C Shaller, Ekaterina Dadachova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignanciesG R Hudes, C E Szarka, A Adams, et al.
American Journal of Clinical Oncology|May 12, 2010
Phase II and coagulation cascade biomarker study of bevacizumab with or without docetaxel in patients with previously treated metastatic pancreatic adenocarcinomaIgor A Astsaturov, Neal J Meropol, R Katherine Alpaugh, et al.
Cancer|March 27, 2018
A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancerMichael J Pishvaian, Rebecca S Slack, Wei Jiang, et al.
Resuscitation|August 19, 2023
Maintaining normothermia immediately after birth in preterm infants <34 weeks' gestation: A systematic review and meta-analysisV V Ramaswamy, J A Dawson, M F de Almeida, et al.
Pageof 129